VietlawOnline

blue-check It is prioritized to grant certificates of free sales to drug for treatment of Covid-19 patients

Official letter No. 9491/QLD-DK dated August 16th, 2021 of the Drug Administration of Vietnam regarding priority to grant certificates of free sale to drugs which are being studied by countries for treatment of Covid-19 patients
Posted: 16/8/2021 11:26:26 AM | Latest updated: 20/8/2021 7:15:52 AM (GMT+7) | LuatVietnam: 5271 | Vietlaw: 523
VietlawOnline

The Drug Administration of Vietnam announces that it will give priority and shorten time of consideration for granting certificates of free sale to drugs which are being studied by countries for Covid-19 prevention and treatment (such as drugs containing Molnupiravir, Favipiravir, Remdesivir, etc.), thereby pharmaceutical companies should promptly submit the application for registration of marketing authorization.

In addition, if there are difficulties and problems relating the submission of application for registration of marketing authorization of drugs for Covid-19 prevention and treatment, units may propose solutions to remove difficulties to the Drug Administration of Vietnam.

Ms Phuong Thao (VietlawOnline.com)
Please tag VietlawOnline.com when reposting this article
Related documents
blue-check 778/TTrB-P3
blue-check 9485/QLD-KD
Penalty document
Unknown
Information
Effective Date Unknown
ExpiredDate Unknown
Published Vietlaw's Newsletter No. 523
Files attachment
enflag pdficon CV9491_16082021QLD[VLO].pdf
Timeline
No data

Covid-19